Drug Targeting Organ-Specific Strategies

330 12 Use of Human Tissue Slices in Drug Targeting Research
[72] Leeman WR, van de Gevel IA, Rutten AAJJL, Toxicol. In Vitro 1995, 9, 291–298.
[73] de Kanter R, Olinga P, de Jager MH, Merema MT, Meijer DKF, Groothuis GMM, Toxicol. In Vitro
1999, 13, 737–744.
[74] de Kanter R, Olinga P, Hof I, de Jager M, Verwillegen WA, Slooff MJ, Koster HJ, Meijer DK,
Groothuis GM, Xenobiotica 1998, 28, 225–234.
[75] Olinga P, Merema M, Hof IH, de Jong KP, Slooff MJH, Meijer DKF, Groothuis GMM, Drug
Metab. Dispos. 1998, 26, 5–11.
[76] Valentovic MA, Ball JG, Anestis DK, Rankin GO, Toxicol. In Vitro 1995, 9, 75–81.
[77] Miller MG, Beyer J, Hall GL, Degraffenried LA, Adams PE, Toxicol. Appl. Pharmacol. 1993, 122,
108–116.
[78] Olinga P, Merema MT, Hof IH, De Jager MH, De Jong KP, Slooff MJH, Meijer DKF, Groothuis
GMM, Xenobiotica 1998, 28, 349–360.
[79] Jansen RW, Olinga P, Harms G, Meijer DKF, Pharm. Res. 1993, 10, 1611–1614.
[80] Sutto F, Brault A, Lepage R, Huet P-M, J. Hepatol. 1994, 20, 611–616.
[81] Olinga P, Hof IH, Smit M, de Jager MH, Nijenhuis E, Slooff MJH, Meijer DKF, Groothuis
GMM, J. Pharm. Toxicol. Methods, 2001 (in press).
[82] Oude Elferink RPJ, Meijer DKF, Kuipers F, Jansen PLM, Groen AK, Groothuis GMM, Biochim.
Biophys. Acta 1995, 1241, 215–268.
[83] Tiribelli C, Reichen J, Meijer DKF, J. Hepatol. 1996, 24, 11–34.
[84] Meijer DKF, In: Handbook of Physiology. The Gastrointestinal System, Vol. III (Eds Schulz J,
Forte G, Rauner BB), pp. 717–758. Oxford University Press, New York, 1989.
[85] Meijer DKF, Ziegler K, In: Biological Barriers to Protein Delivery (Eds Audus KL, Raub TJ), pp.
339–407. Plenum Press, New York and London, 1993.
[86] Jansen RW, Kruijt JK, van Berkel TJ, Meijer DK, Hepatology 1993, 18, 146–152.
[87] Olinga P, Merema MT, Hof IH, Slooff MJH, Proost JH, Meijer DKF, Groothuis GMM, J. Pharmacol.
Exp. Ther. 1998, 285, 506–510.
[88] Sandker GW, Weert B, Olinga P, Wolters H, Slooff MJH, Meijer DKF, Groothuis GMM,
Biochem. Pharmacol. 1994, 47, 2193–2200.
[89] Schanker LS, Solomon HM, Am. J. Physiol. 1963, 204, 829–832.
[90] Hedman A, Meijer DKF, J. Pharm. Sci. 1998, 87, 457–461.
[91] Hedman A, Meijer DK, J. Hepatol. 1998, 28, 240–249.
[92] Olinga P, de Kanter R, Hof IH, de Jager MH, Slooff MJH, Koster HJ, Meijer DKF, Groothuis
GMM, Hepatology 1996, 24, 468A.
[93] Thompson MB, Davis DG, Morris RW, J. Lipid Res. 1993, 34, 553–561.
[94] Beljaars L, Molema G, Weert B, Bonnema H, Olinga P, Groothuis GMM, Meijer DKF, Poelstra
K, Hepatology 1999, 29, 1486–1493.
[95] Beljaars L, Molema G, Schuppan D, Geerts A, De Bleser PJ, Weert B, Meijer DKF, Poelstra K,
J. Biol. Chem. 2000, 275, 12743–12751.
[96] Aono K, Isobe K, Kiuchi K, Fan ZH, Ito M, Takeuchi A, Miyachi M, Nakashima I, Nimura Y, J.
Cell Biochem. 1997, 65, 349–358.
[97] Van Bossuyt H, De Zanger RB, Wisse E, J. Hepatol. 1988, 7, 325–337.
[98] Billiar TR, Curran RD, Ferrari FK, Williams DL, Simmons RL, J. Surg. Res. 1990, 48, 349–353.
[99] Vos TA, Gouw AS, Klok PA, Havinga R, van Goor H, Huitema S, Roelofsen H, Kuipers F,
Jansen PL, Moshage H, Gastroenterology 1997, 113, 1323–1333.
[100] Nussler AK, Di Silvio M, Liu ZZ, Geller DA, Freeswick P, Dorko K, Bartoli F, Billiar TR, Hepatology
1995, 21, 1552–1560.
[101] Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M, Hepatology 1994, 19, 480–488.
[102] Sultan K, Hartung J, Bade EG, FEBS Lett. 1996, 394, 51–54.
[103] Melgert BN, Olinga P, Jack VK, Molema G, Meijer DKF, Poelstra K, J. Hepatol. 2000, 32,
603–611.
[104] Olinga P, Merema MT, de Jager MH, Slooff MJH, Limburg PC, Bijzet J, Poelstra K, Meijer DKF,
Groothuis GMM, Hepatology 1998, 28, 184A.
[105] Stijntjes GJ, Commandeur JN, te Koppele JM, McGuinness S, Gandolfi AJ, Vermeulen NP, Toxicology
1993, 79, 67–79.
[106] Vickers AEM, Fisher RL, Brendel K, Guertler J, Dannecker R, Keller B, Fischer V, Drug Metab.
Dispos. 1995, 23, 327–333.
[107] Foulkes EC, Proc. Soc. Exp. Biol. Med. 1996, 211, 155–162.
[108] Ruegg CE, Gandolfi AJ, Nagle RB, Krumdieck CL, Brendel K, J. Pharmacol. Methods 1987, 17,
111–123.